Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study-Reference-Cited by-同舟云学术

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Published:2002-03 Issue:9309 Volume:359 Page:824-830
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zander Mette,Madsbad Sten,Madsen Jan Lysgaard,Holst Jens Juul

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus;Turner;Ann Intern Med,1996

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

3. Glucagon-like peptide-1 7–36: a physiological incretin in man;Kreymann;Lancet,1987

4. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9–39;Edwards;Diabetes,1999

5. Effect of nutrient ingestion on glucagon-like peptide 1 (7–36 amide) secretion in human type 1 and type 2 diabetes;Lugari;Horm Metab Res,2000

Cited by 1138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of continuous glucose monitoring when initiating glucagon‐like peptide‐1 receptor agonist therapy in insulin‐treated diabetes;Diabetes, Obesity and Metabolism;2024-08-28

2. GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management;Nature Metabolism;2024-08-19

3. Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor;Journal of Medicinal Chemistry;2024-08-14

4. The impact of obesity on reproductive health and metabolism in reproductive-age females;Fertility and Sterility;2024-08

5. The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis;Clinical Gastroenterology and Hepatology;2024-08